Xoma Corp entered into a Traditional Royalty Purchase Agreement and a Synthetic Royalty Purchase Agreement with Dar Bioscience, Inc., paying $22 million in cash for the sale of royalties and potential commercial milestones.
AI Assistant
XOMA ROYALTY CORP
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.